| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 02/11/2004 | EP1387687A2 Novel use |
| 02/11/2004 | EP1387686A1 Timing and duration of administration of adenosine a1/a2 agonist for cardioprotection |
| 02/11/2004 | EP1387685A1 Analgesic composition and method |
| 02/11/2004 | EP1387684A1 Compositions comprising lopinavir and methods for enhancing the bioavailability of pharmaceutical agents |
| 02/11/2004 | EP1387683A1 Novel salt and crystalline forms of (2r)-anti-5-3-(4-(10,11-difluoromethanodibenzosuber-5-yl)piperazin-1-yl)-2-hydroxypropoxy quinoline |
| 02/11/2004 | EP1387682A1 Treatment of adhd |
| 02/11/2004 | EP1387681A2 Antiviral compounds |
| 02/11/2004 | EP1387680A1 Benzimidazole derivatives as therapeutic agents |
| 02/11/2004 | EP1387679A1 Sulfonamides |
| 02/11/2004 | EP1387678A1 Compounds that inhibit hsp90 and stimulate hsp70 and hsp40, useful in the prevention or treatment of diseases associated with protein aggregation and amyloid formation |
| 02/11/2004 | EP1387677A2 Method of treating hematologic tumors and cancers using beta lapachone |
| 02/11/2004 | EP1387676A2 Compositions comprising an anti-microtubule agent and a polypeptide or a polysaccharide and the use thereof for the preparation of a medicament for the treatment of inflammatory conditions |
| 02/11/2004 | EP1387675A2 Liquid formulation of metformin |
| 02/11/2004 | EP1387674A2 Hedgehog antagonists, methods and uses related thereto |
| 02/11/2004 | EP1387673A1 Abuse-resistant controlled-release opioid dosage form |
| 02/11/2004 | EP1387665A2 System for delivering cosmetics and pharmaceuticals |
| 02/11/2004 | EP1328282A4 Efficient method for producing compositions enriched in anthocyanins |
| 02/11/2004 | EP1300394B1 Method for the production of a water-dispersible formulation containing carotenoids |
| 02/11/2004 | EP1299356B1 Novel compounds |
| 02/11/2004 | EP1240157B1 Substituted n-benzyl-indol-3-yl glyoxylic acid derivatives having an anti-tumoral effect |
| 02/11/2004 | EP1235569B1 Medicament and combination of compatible medicaments |
| 02/11/2004 | EP1231908B1 Pharmaceutical composition comprising a no donor compound and its use |
| 02/11/2004 | EP1227795B1 Lipid complex of alkycyclines |
| 02/11/2004 | EP1224177B1 Process for preparing oxazolines from tetrahydrofurans |
| 02/11/2004 | EP1216239B1 Piperazine derivatives as 5-ht1b antagonists |
| 02/11/2004 | EP1183251B1 Indolylpiperidine derivatives as antihistaminic and antiallergic agents |
| 02/11/2004 | EP1180944B1 Compositions containing creatine in suspension |
| 02/11/2004 | EP1180033B1 Lamivudine containing pharmaceutical formulation |
| 02/11/2004 | EP1176962B1 Liposome compositions for improved drug retention |
| 02/11/2004 | EP1168931B1 Method of using emamectin to treat fish parasites |
| 02/11/2004 | EP1165491B1 Lta4 hydrolase inhibitors |
| 02/11/2004 | EP1157998B1 Heterocyclic compounds, intermediates thereof and elastase inhibitors |
| 02/11/2004 | EP1144393B1 Benzoxazole derivatives for use as integrin inhibitors |
| 02/11/2004 | EP1139781B1 Food or veterinary composition for domestic carnivores containing free tyrosine |
| 02/11/2004 | EP1126822B1 Controlled release liquid delivery compositions with low initial drug burst |
| 02/11/2004 | EP1123087A4 Oral pulsed dose drug delivery system |
| 02/11/2004 | EP1089961B1 Benflumetol derivatives and their use against parasitical protozoa and trematodes |
| 02/11/2004 | EP1089620B1 Hydrophilic polymer blends used to prevent cow skin infections |
| 02/11/2004 | EP1086113B1 Benzothiepine-1,1-dioxide derivatives, method for producing them, medicaments containing these compounds and their use |
| 02/11/2004 | EP1079808B1 Thermoprotected microparticle compositions and process for terminal steam sterilization thereof |
| 02/11/2004 | EP1069902B1 Use of phospholipids for the manufacture of a medicament for the prevention of adhesions |
| 02/11/2004 | EP1047411B1 Substituted diphenyl indanone, indane and indole compounds and analogues thereof useful for the treatment or prevention of diseases characterized by abnormal cell proliferation |
| 02/11/2004 | EP1042300B1 Phthalazine derivatives useful as phosphodiesterase 4 inhibitors |
| 02/11/2004 | EP1032561B1 Substituted oximes as neurokinin antagonists |
| 02/11/2004 | EP1028725B1 Use of vasopressin antagonists for treating disturbances or illnesses of the inner ear |
| 02/11/2004 | EP1007020B1 9-cis-RETINOIC ACID FOR CELL-MEDIATED IMMUNE DISEASES |
| 02/11/2004 | EP1006110B1 Derivatives of acyl-piperazinil-pyrimidins, preparation thereof and application as medicaments |
| 02/11/2004 | EP1003373B1 Compositions and methods for reducing respiratory depression and attendant side effects of mu opioid compounds |
| 02/11/2004 | EP0994716B1 Maternal immune secretions and their use in the treatment and/or prophylaxis of conditions of the human body |
| 02/11/2004 | EP0936912B1 Inhibitors of cysteine protease |
| 02/11/2004 | EP0892640B1 Enteric-coated pharmaceutical compositions of mycophenolate |
| 02/11/2004 | EP0888452B1 Human cyr61, an extracellular matrix signalling molecule |
| 02/11/2004 | EP0862615B1 Immunity against pasteurella haemolytica leukotoxin |
| 02/11/2004 | EP0862575B1 Novel geranylgeranyl-derivatives, process for the preparation thereof and related pharmaceutical compositions |
| 02/11/2004 | EP0859608B1 Treating niddm with rxr agonists |
| 02/11/2004 | EP0835125B1 Cd4-derived peptides that inhibit immune responses |
| 02/11/2004 | EP0832094B1 Aminosterol compounds useful as inhibitors of the sodium/proton exchanger (nhe), pharmaceutical methods and compositions employing such inhibitors, and processes for evaluating the nhe-inhibitory efficacy of compounds |
| 02/11/2004 | EP0820288B1 Use of dextromethorphan or dextrorphan for the treatment of urinary incontinence |
| 02/11/2004 | EP0797567B1 Novel amino acid derivatives with improved multi-drug resistance activity |
| 02/11/2004 | EP0781127B1 Anaesthetic analgesic gas mixtures containing enflurane or isoflurane in combination with sevoflurane or desflurane |
| 02/11/2004 | EP0755385B1 Chelant compounds |
| 02/11/2004 | CN1474828A Erythromycin derivative having novel crystal structures and process for their production |
| 02/11/2004 | CN1474822A Novel 4'-demethyl-4'-0-substituted-1-deoxypodophyllotoxin derivative and geometric isomer thereof, process for preparation thereof and anti-cancer composition comprising same |
| 02/11/2004 | CN1474821A New cephalotaxanes, their method of preapartion and their use in treatment of cancers, leukemias, parasites including thus resistant to usual chemotherapentic agents and reversal agents |
| 02/11/2004 | CN1474820A Benzodiazepine derivatives as GABA A receptor modulators |
| 02/11/2004 | CN1474819A Novel imidazole derivatives, production method thereof and use thereof |
| 02/11/2004 | CN1474818A Preventive or therapeutic medicines for diabetes, containing fused heterocycle compounds or their salts |
| 02/11/2004 | CN1474816A 4-amino-quinazolines |
| 02/11/2004 | CN1474815A 4-amino-quinazolines |
| 02/11/2004 | CN1474813A Substituted 2-phenylaminomidazoline phenyl ketone derivatives as IP antagonists |
| 02/11/2004 | CN1474812A (Dihydro) isoquinoline derivatives as phosphodiesterase inhibitor |
| 02/11/2004 | CN1474810A Substituted urea neuropeptide YY5 antagonists |
| 02/11/2004 | CN1474805A 2-amino-2-alkyl-5-heptenoic and heptynoic acid derivatives useful as nitric oxide synthase inhibitors |
| 02/11/2004 | CN1474804A 2-amino-2-alkyl-4-hexenoic and hexynoic acid derivatives useful as nitric oxide synthase inhibitors |
| 02/11/2004 | CN1474797A Retiferol derivatives and their use in treatment of skin diseases or conditions associated with photodamage |
| 02/11/2004 | CN1474702A Oral pharmaceutical composition containing a block copolymer |
| 02/11/2004 | CN1474701A Wild apple polyphenol and process for producing the same |
| 02/11/2004 | CN1474700A Pharmaceutical compositions for treatment of mucositis, stomatitis and Behchet's syndrome |
| 02/11/2004 | CN1474699A Remedies for diabetes |
| 02/11/2004 | CN1474698A Formulation containing phosphate derivatives of electron transfer agents |
| 02/11/2004 | CN1474697A Complexes of phosphate derivatives |
| 02/11/2004 | CN1474696A Novel pharmacentical compositions with anti-diabetic activity and method for preparing same |
| 02/11/2004 | CN1474693A Use of thienopyrimidines |
| 02/11/2004 | CN1474692A Treatment of premature ejaculation |
| 02/11/2004 | CN1474691A Novel uses of combined 5-HT 1A agonists and serotonin reuptake inhibitor |
| 02/11/2004 | CN1474690A Synergestic combinations comprising renin inhibitor for cardiovascular diseases |
| 02/11/2004 | CN1474689A CDC25 phosphatase inhibitors |
| 02/11/2004 | CN1474688A Novel uses of combined selective dopamine D2 receptor antagonists and 5-HT1A receptor agonists |
| 02/11/2004 | CN1474687A Mdeicine based on anti-hyperglycaemic microcapsules with prolonged release |
| 02/11/2004 | CN1474686A Hydrolytically unstable compositions |
| 02/11/2004 | CN1474684A Cosmetic method of treating skin |
| 02/11/2004 | CN1474683A Cosmetic and pharmaceutical composition and its use |
| 02/11/2004 | CN1473926A Sulfated NF1 granulose-anti-AIDS medicine and its preparing method |
| 02/11/2004 | CN1473855A Sulfuric galactosan and use of its derivative |
| 02/11/2004 | CN1473840A Gene sequence of rockfish pituitary rich in reproductive control factor and its use |
| 02/11/2004 | CN1473838A Extracting and refining process for alfalfa saponin and alfalfa saponin preparation |
| 02/11/2004 | CN1473837A Stem clasping gut weed lactone and its derivative composition and its preparing method and its use |
| 02/11/2004 | CN1473831A Process for preparing pyrazolo (4,3-d) pyrimidine-7-ketone and its intermediate |
| 02/11/2004 | CN1473827A 3-position substituted quinolone derivativers and its use in pharmacy |
| 02/11/2004 | CN1473621A Medicinal new dosage form comtaining SA liposome as medicine carrier |